What’s driving consumer desire for immune health support in 2024 – white paper
Understanding consumers is more important than ever — and the market for immune support products shows no sign of slowing down. A new consumer study from Kyowa Hakko offers exclusive access to consumer data and formulation opportunities with IMMUSE™, a cutting-edge postbiotic.
June 14, 2024
Sponsored by Kyowa Hakko
As more consumers explore the immune health market, connecting with them is more important than ever. In a new consumer insights study from Kyowa Hakko, get exclusive access to consumer behavioral data about lifestyle and behavior changes post-pandemic, key motivators behind their interest in health, and emotional need states.
IMMUSE™ is a cutting-edge postbiotic — the first of its kind to activate pDC cells for year-round immune support. PDCs are a type of immune cell that act as leaders of the immune system. Once activated, they recruit, stimulate, and organize other key immune cells for true, comprehensive support at the cellular level.
Unlock crucial consumer insights and formulation opportunities with clinically researched immune support from IMMUSE™. Download the white paper now to learn more.
Read more about:
White papersYou May Also Like